$24.190
+0.743 (+3.07%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BEAM Prediction & Forecast by Similar Chart Analysis
Alphio's BEAM stock price prediction model matches the current Beam Therapeutics Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $24.22 (+0.14%). The 1-week path is $24.33 (+0.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Beam Therapeutics Inc. Stock?
Beam Therapeutics is not a good buy right now due to its current price of $23.47, which is significantly below the analyst price target of $43. The stock has a low RSI of 36.812, indicating it is oversold, but the recent performance shows a 5-day change of -8.68% and a year-to-date change of -13.52%. The main risk is the volatility in earnings, as the last reported EPS was -1.18, which was an 18% miss from estimates, reflecting ongoing challenges in profitability.
BEAM stock price ended at $24.19 on Monday, after rising +3.07%
Beam Therapeutics Inc. (BEAM) last closed at $24.19, gaining +3.07%. These facts feed the 1-day and 1-week BEAM price prediction above.
Forecast Drivers
Beam Therapeutics Inc. (BEAM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BEAM, ranked by similarity.
Seasonality analysis for BEAM
Historically the probability of a positive October return for BEAM is 35.00%. February offers the highest probability of a positive month at 84.48%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BEAM
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $13.73 | $13.79 | $19.04 | -43.00% |
| Nov 2026 | $13.49 | $15.16 | $16.84 | -37.34% |
| Dec 2026 | $11.13 | $12.36 | $14.05 | -48.90% |
In 2026, Beam Therapeutics Inc. (BEAM) is projected to range from $11.13 to $19.04.
Beam Therapeutics Inc. 2026 monthly forecast
In Oct 2026, Beam Therapeutics Inc. is projected to average $13.79, with a low of $13.73 and high of $19.04.
In Nov 2026, Beam Therapeutics Inc. is projected to average $15.16, with a low of $13.49 and high of $16.84.
In Dec 2026, Beam Therapeutics Inc. is projected to average $12.36, with a low of $11.13 and high of $14.05.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.